Nourkrin is a hair growth supplement marketed towards men and women suffering from androgenic alopecia (genetic hair loss). Nourkrin is said to regulate the hair growth cycle thus, reducing the rate of hair loss in men and women. Unfortunately, most of the products on the market today do nothing besides "promote" hair growth, which does absolutely nothing to stop the progression of androgenic alopecia or genetic hair loss. In this article, we will be discussing Nourkrin as a "possible" hair loss solution.
What is Nourkrin?
Nourkrin is a hair loss supplement that is marketed towards men and women suffering from androgenic alopecia (genetic hair loss), the supplement comes in a 30-day supply of 60 tablets. According to Nourkrin, hair loss is caused by a disrupted hair growth cycle, which leads to increased hair shedding thus, causing the hair to appear thinner. As reported by Nourkrin, the supplment works by regulating the hair growth cycle.
What Are The Ingredients in Nourkrin?
Marilex 600mg, Acerola Cherry Extract 240mg, Fenugreek 90mg, Silica 60mg, Horsetail Extract 50 mg, Cod Liver Oil Extract 20 mg and D-Biotin 180ug. It is important to unerstand that Marilex is a propietary blend of fractioned fish extract with specific lectican proteoglycans, which is essentially a type of protein that is attached to negatively charged polysaccharides (polymeric carbohydrate). Certain lecticans like aggrecan are a major component of extracellular matrix in cartilage however, versican (lectican) is a component of connective tissues including skin cells. None of the listed ingredients have been approved by the FDA to treat androgenic alopecia (genetic hair loss).
Do The Ingredients Actually Stop Hair Loss?
None of the listed ingredients stop, slow or reverse the progression of androgenic alopecia (genetic hair loss) however, the website doesn't specifically state it treats androgenic alopecia (genetic hair loss). According to the Nourkrin website, Nourkrin is for the "health-conscious, modern man" that want's to maintain a normal hair growth cycle, which "helps support normal healthy hair growth". There is an important distinction between preventing, slowing or even stopping the progression of androgenic alopecia (genetic hair loss) and supporting normal healthy hair growth. Technically, a balanced diet, good sleep and stress reduction all "help support normal healthy hair growth" without the need to buy any supplements. Furthermore, none of the ingredients listed are FDA approved to treat androgenic alopecia (genetic hair loss). In fact, most of the ingredients can be purchased separately for an exceptionally low price from most supplement stores.
What Causes Androgenic Alopecia (Genetic Hair Loss)
The short answer is genetics however, the exact mechanism that triggers hair loss is hormonal. Hair follicles, as well as sebaceous glands contain a high level of an enzyme called 5-alpha reductase. The 5-alpha reductase enzyme is responsible for converting testosterone into dihydrotestosterone (DHT) through the blood stream. DHT is the main hormone responsible for causing hair loss in both men and women. Overtime DHT will bind to vulnerable hair follicle receptors and shrink the hair follicle until it no longer grows, this process is called "miniaturization". However, DHT only affects those hair follicles that are genetically vulnerable to the effects of the hormone.
It is important to understand the difference between treating androgenic alopecia (genetic hair loss) and "supporting normal healthy hair growth". Individuals may support normal healthy hair growth by making lifestyle changes such as exercising, eating a well-balanced diet, decreasing their stress and improving their sleeping patterns. Currently, there are only two products on the market that are approved by the FDA to treat androgenic alopecia they are Rogaine (minoxidil) and Propecia (finasteride).
Written and published by,Melvin- Editorial Assistant and Forum Co-Moderator for the Hair Transplant Network and The Coalition of Independent Hair Restoration Physicians
© 2001 - 2018 Media Visions, Inc